| scholarly article | Q13442814 |
| P50 | author | Hediye Erdjument-Bromage | Q25910537 |
| Wei Li | Q42789793 | ||
| Ryohei Ishii | Q55270467 | ||
| Paul Tempst | Q25912123 | ||
| P2093 | author name string | Gaia Schiavon | |
| Jonathan Cooper | |||
| Lu Zhou | |||
| Marco Giovannini | |||
| Pengbo Zhou | |||
| Filippo G Giancotti | |||
| C Oliver Hanemann | |||
| Stephen B Long | |||
| Liru You | |||
| Angela Pepe-Caprio | |||
| P2860 | cites work | Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase | Q24298753 |
| The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage | Q24301297 | ||
| A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1 | Q24301361 | ||
| Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation | Q24307387 | ||
| Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase | Q24321736 | ||
| TEAD mediates YAP-dependent gene induction and growth control | Q24336045 | ||
| Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle | Q24680705 | ||
| Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex | Q37432747 | ||
| Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L | Q37709703 | ||
| Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma | Q40075297 | ||
| Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation. | Q40077047 | ||
| Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. | Q40284714 | ||
| Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin. | Q40484684 | ||
| Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization | Q40758119 | ||
| Functional analysis of neurofibromatosis 2 (NF2) missense mutations | Q40793131 | ||
| An alternative domain determines nuclear localization in multifunctional protein 4.1. | Q41035102 | ||
| Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells | Q41740694 | ||
| Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15. | Q42810615 | ||
| The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. | Q42823880 | ||
| Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. | Q54785852 | ||
| Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells | Q73424194 | ||
| Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings | Q80287223 | ||
| Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain | Q27637088 | ||
| Wnt/beta-catenin signaling in development and disease | Q27860784 | ||
| p21-activated kinase links Rac/Cdc42 signaling to merlin | Q28207198 | ||
| VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation | Q28272241 | ||
| Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin | Q28275474 | ||
| A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth | Q28282803 | ||
| CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis | Q28508809 | ||
| NF2deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions | Q28511556 | ||
| Merlin, the Product of the Nf2 Tumor Suppressor Gene, Is an Inhibitor of the p21-Activated Kinase, Pak1 | Q28513718 | ||
| Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures | Q29547700 | ||
| Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain | Q29614381 | ||
| Elucidation of a universal size-control mechanism in Drosophila and mammals | Q29618935 | ||
| ERM proteins and merlin: integrators at the cell cortex | Q29619893 | ||
| Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling | Q30411760 | ||
| Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling | Q30437229 | ||
| Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane | Q30443407 | ||
| Examination of micro-tip reversed-phase liquid chromatographic extraction of peptide pools for mass spectrometric analysis | Q31943093 | ||
| The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis | Q34474913 | ||
| Delineation of a Fat tumor suppressor pathway | Q34566699 | ||
| DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase | Q34641190 | ||
| Isolation and mass spectrometry of transcription factor complexes | Q34675839 | ||
| Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development | Q34793207 | ||
| Contact-dependent inhibition of EGFR signaling by Nf2/Merlin | Q36118464 | ||
| Ubiquitin proteasome system (UPS): what can chromatin do for you? | Q36741709 | ||
| Hippo signaling in organ size control | Q36793377 | ||
| Shedding light on Merlin's wizardry | Q36795086 | ||
| Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R. | Q36878513 | ||
| Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression | Q36909853 | ||
| NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth | Q37275182 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurofibromin 2 | Q410233 |
| DDB1 and CUL4 associated factor 1 | Q21112163 | ||
| P304 | page(s) | 477-90 | |
| P577 | publication date | 2010-02-19 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus | |
| P478 | volume | 140 |
| Q59357522 | A genome-wide screen of Epstein-Barr virus proteins that modulate host SUMOylation identifies a SUMO E3 ligase conserved in herpesviruses |
| Q26830181 | A neuronal function of the tumor suppressor protein merlin |
| Q33576268 | A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. |
| Q24299493 | A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions |
| Q50879137 | An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis. |
| Q92505476 | An update on the CNS manifestations of neurofibromatosis type 2 |
| Q34479368 | Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway |
| Q39282242 | Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP. |
| Q46412577 | Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival. |
| Q92658098 | BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling |
| Q55130390 | Back to the future: proceedings from the 2010 NF Conference. |
| Q35120841 | Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes |
| Q36180198 | CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10. |
| Q55638662 | CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. |
| Q53474278 | Cancer: a new role for non-canonical Hippo signaling. |
| Q37478763 | Cell competition and its implications for development and cancer |
| Q38857144 | Cellular Organization and Cytoskeletal Regulation of the Hippo Signaling Network. |
| Q38697736 | Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours |
| Q40316013 | Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1VprBP. |
| Q37090808 | Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future |
| Q30364937 | Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. |
| Q53316010 | Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis. |
| Q35208467 | Comparative RNAi screening identifies a conserved core metazoan actinome by phenotype. |
| Q33616271 | Compensatory cellular hypertrophy: the other strategy for tissue homeostasis. |
| Q57266579 | Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2 |
| Q57172733 | Contemporary Molecular Biology of Sporadic Vestibular Schwannomas: A Systematic Review and Clinical Implications |
| Q30464280 | Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxides. |
| Q38514410 | Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway |
| Q57460410 | Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology |
| Q34365216 | Cullins and cancer |
| Q36506967 | DCAF1 controls T-cell function via p53-dependent and -independent mechanisms |
| Q54282272 | DNA copy gains of tumor-related genes in vestibular schwannoma. |
| Q35099829 | Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest |
| Q38190332 | Deregulation of cell signaling in cancer |
| Q89104578 | Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma |
| Q33906075 | Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns |
| Q28086765 | Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B |
| Q41834097 | Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity |
| Q89458203 | EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma |
| Q37885731 | Emerging therapeutic targets in schwannomas and other merlin-deficient tumors |
| Q39149856 | Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells |
| Q47138523 | Essential signaling in NF2 loss-related tumours: the therapeutic potential of CRL4DCAF1 and mTOR combined inhibition |
| Q35096540 | FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function |
| Q39651925 | Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling |
| Q38441711 | Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas |
| Q39866397 | Genetic heterogeneity and chromatin modifiers in renal clear cell carcinoma |
| Q86380048 | Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster |
| Q33809716 | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. |
| Q30453465 | Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32. |
| Q55122992 | Hippo Signaling Circuit and Divergent Tissue Growth in Mammalian Eye. |
| Q36546520 | Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression |
| Q28088294 | Hippo/YAP pathway for targeted therapy |
| Q42143834 | Important recent insights into the genetics and biology of malignant pleural mesothelioma |
| Q37880216 | Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation |
| Q37528252 | Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. |
| Q33673563 | Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas |
| Q92480194 | Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance |
| Q53075204 | Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2. |
| Q30458195 | Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells |
| Q40667179 | Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma |
| Q37843031 | Mammalian Hippo pathway: from development to cancer and beyond |
| Q41636971 | Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation |
| Q30373369 | Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury. |
| Q39069340 | Merlin sumoylation is required for its tumor suppressor activity |
| Q34620864 | Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1) |
| Q38010858 | Merlin, a multi-suppressor from cell membrane to the nucleus |
| Q35670477 | Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/β-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways |
| Q36296784 | Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling |
| Q24300770 | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus |
| Q35880377 | Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. |
| Q34366142 | Methylation of histone H4 at aspartate 24 by protein L-isoaspartate O-methyltransferase (PCMT1) links histone modifications with protein homeostasis |
| Q41933714 | MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer |
| Q91659438 | MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer |
| Q30456266 | Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation |
| Q30494424 | Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants |
| Q37330688 | Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. |
| Q28241032 | Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study |
| Q38204110 | Molecular insights into NF2/Merlin tumor suppressor function |
| Q30457681 | Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms |
| Q38107102 | Molecular pathogenesis of malignant mesothelioma |
| Q37811893 | Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development |
| Q42608826 | Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin |
| Q41492288 | NF2 Activates Hippo Signaling and Promotes Ischemia/Reperfusion Injury in the Heart. |
| Q36273267 | NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition |
| Q55355075 | NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma. |
| Q30440530 | NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations |
| Q35882200 | Netrin-4 promotes glioblastoma cell proliferation through integrin β4 signaling |
| Q42662364 | Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. |
| Q26825296 | Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator |
| Q55234046 | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. |
| Q30459213 | Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma |
| Q35218073 | Neurofibromatosis-related tumors: emerging biology and therapies |
| Q41669132 | Neurovascular patterning cues and implications for central and peripheral neurological disease |
| Q36205186 | New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment |
| Q39455555 | Novel insights into mesothelioma biology and implications for therapy. |
| Q30398838 | Oncogenic role of Merlin/NF2 in glioblastoma |
| Q57266478 | Pathogenesis and management of type 2 neurofibromatosis |
| Q35971298 | Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease |
| Q96950908 | Pathomechanisms in schwannoma development and progression |
| Q92572049 | Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival |
| Q38736783 | Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation |
| Q35665751 | Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response |
| Q34062012 | Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas |
| Q90250769 | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins |
| Q28730289 | Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis |
| Q38455974 | Rac1 controls Schwann cell myelination through cAMP and NF2/merlin |
| Q41073081 | Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression. |
| Q38979328 | Regulation of Drosophila glial cell proliferation by Merlin-Hippo signaling |
| Q26863645 | Regulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factors |
| Q30352874 | Regulation of localization and function of the transcriptional co-activator YAP by angiomotin. |
| Q49797883 | Regulation of the Hippo Signaling Pathway by Ubiquitin Modification |
| Q36478653 | Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. |
| Q36189820 | Role of Merlin/NF2 inactivation in tumor biology |
| Q27331510 | Schwann cells induce cancer cell dispersion and invasion. |
| Q38180808 | Schwannomas and their pathogenesis |
| Q38365768 | Searching for targets for the systemic therapy of mesothelioma. |
| Q24323074 | Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2 |
| Q36425527 | Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane |
| Q27683013 | Structural Basis of the Binding of Merlin FERM Domain to the E3 Ubiquitin Ligase Substrate Adaptor DCAF1 |
| Q27690668 | Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function |
| Q57066266 | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors |
| Q37827165 | Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer |
| Q52642770 | Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma. |
| Q38997320 | The Emerging Role of TRAF7 in Tumor Development |
| Q37802193 | The FERM domain: organizing the structure and function of FAK. |
| Q24603986 | The Hippo Signaling Pathway in Development and Cancer |
| Q37800053 | The Hippo pathway in biological control and cancer development |
| Q34077795 | The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals |
| Q34202686 | The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy |
| Q91937389 | The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling |
| Q30606515 | The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway |
| Q52594766 | The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas. |
| Q33658238 | The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club |
| Q38148036 | The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms |
| Q38757064 | The hippo signaling pathway: implications for heart regeneration and disease |
| Q39869336 | The hippo tumor suppressor network: from organ size control to stem cells and cancer |
| Q30467803 | The molecular biology of vestibular schwannomas and its association with hearing loss: a review. |
| Q41135859 | The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours |
| Q26783814 | The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications |
| Q87424317 | The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals |
| Q42509945 | The role of insulin-like growth factors signaling in merlin-deficient human schwannomas. |
| Q40343618 | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors |
| Q30418605 | Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2. |
| Q37478758 | Tissue repair through cell competition and compensatory cellular hypertrophy in postmitotic epithelia |
| Q36873743 | Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1. |
| Q30572320 | Tumor suppressor NF2/Merlin is a microtubule stabilizer |
| Q36063647 | Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex |
| Q64253417 | Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition |
| Q54973587 | Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer. |
| Q53116195 | Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. |
| Q53083642 | Update from the 2013 International Neurofibromatosis Conference. |
| Q54113157 | VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin. |
| Q24594980 | Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail |
| Q34986007 | VprBP (DCAF1): a promiscuous substrate recognition subunit that incorporates into both RING-family CRL4 and HECT-family EDD/UBR5 E3 ubiquitin ligases |
| Q24299516 | VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity |
| Q24338707 | VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription |
| Q91771314 | VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation |
| Q38833602 | VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1. |
| Q38437859 | YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis |
| Q91823921 | YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells |
| Q52991168 | [Pathogenesis and molecular pathology of vestibular schwannoma]. |
| Q41143945 | p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during in vitro tumor progression |
| Q30401833 | p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB. |
Search more.